Literature DB >> 2912601

Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms.

T Nakajima1, Y Kurachi, H Ito, R Takikawa, T Sugimoto.   

Abstract

Effects of quinidine, disopyramide, and procainamide on the acetylcholine (ACh)-induced K+ channel current were examined in single atrial cells, using the tight-seal, whole-cell clamp technique. The pipette solution contained guanosine-5'-triphosphate (GTP) or guanosine-5'-O-(3-thiotriphosphate) (GTP-gamma S, a nonhydrolysable GTP analogue). In GTP-loaded cells, not only ACh but also adenosine induced a specific K+ channel current via GTP-binding proteins (G) by activating muscarinic ACh or adenosine receptors. Quinidine and disopyramide depressed the ACh-induced K+ current quite effectively. Procainamide had a weak inhibitory effect. Quinidine also depressed adenosine-induced K+ current, while the effect of disopyramide on adenosine-induced current was much smaller than that on ACh-induced current. In GTP-gamma S-loaded cells, the K+ channel was uncoupled from the receptors and was activated irreversibly, probably due to direct activation of G proteins by GTP-gamma S. Quinidine depressed the GTP-gamma S-induced K+ current just as in the cases of ACh- and adenosine-induced currents of GTP-loaded cells. Disopyramide had only a weak inhibitory effect and procainamide showed no effect. From these results, it is strongly suggested that the major mechanisms underlying the anti-cholinergic effects of quinidine, disopyramide, and procainamide are different; quinidine may inhibit the muscarinic K+ channel itself and/or G proteins, while disopyramide and high doses of procainamide may mainly block functions of muscarinic ACh receptors in atrial myocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912601     DOI: 10.1161/01.res.64.2.297

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.

Authors:  H Nakaya; Y Furusawa; T Ogura; M Tamagawa; H Uemura
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Anticholinergic action of quinidine sulfate in the rabbit atrioventricular node.

Authors:  M Nishimura; R M Huan; Y Habuchi; N Homma; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.

Authors:  Y Ohmoto-Sekine; H Uemura; M Tamagawa; H Nakaya
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Two distinct types of inwardly rectifying K+ channels in bull-frog atrial myocytes.

Authors:  R B Clark; T Nakajima; W Giles; K Kanai; Y Momose; G Szabo
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

5.  Electrophysiologic actions of aprindine in rabbit atrioventricular node.

Authors:  H Tanaka; M Nishimura; N Homma; Y Habuchi; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

6.  Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.

Authors:  H Uemura; Y Hara; M Endou; K Mori; H Nakaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

7.  A method for the harvest, culture, and characterization of human adult atrial myocardial cells: correlation with age of donor.

Authors:  D A Smith; J L Glover; L E Townsend; D E Maupin
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

8.  Inhibition of the muscarinic receptor-activated K+ current by N-ethylmaleimide in rabbit heart.

Authors:  T Nakajima; M Kaibara; H Irisawa; W Giles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

9.  SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.

Authors:  Y Hara; H Nakaya
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.

Authors:  N Inomata; T Ohno; T Ishihara; N Akaike
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.